Michael J. Brunelle

OncoPlex Diagnostics, Inc. operates a cancer diagnostics laboratory. It provides information that helps physicians choose targeted therapies and avoid therapies. The company is headquartered in Rockville, MD.

Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.

Exploration Aurtois, Inc. engages in the provision of mineral exploration and development. The firm focuses on gold and other mineral deposits. The company was founded on February 3, 2005 and is headquartered in Belleterre, Canada.

Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL

Part of CVS Health Corp., Pharm Plus Resources, Inc. is a company that provides pharmaceutical delivery and reimbursement services. The company is based in Van Nuys, CA. Pharm Plus Resources was acquired by US Bioservices Corp., part of CVS Health Corp. from January 17, 2003 on September 16, 2002.